Press releases
Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
30 May 24
Press Releases
Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder
7 May 24
Health Care, Press Releases, General
Incannex Healthcare Inc. Quarterly Update, Q1 2024
16 Apr 24
Press Releases, General